Edwards gets U.S. approval for 3rd generation heart valve

June 17, 2015 8:00 PM

27 0

June 17 The U.S. Food and Drug Administration on Wednesday said it approved Edwards Lifesciences Corp's Sapien 3 heart valve, the third-generation version of the company's system for replacing diseased aortic valves.

The FDA approved use of the transcatheter aortic valve replacement (TAVR) system for patients unlikely to survive traditional open heart surgery and those deemed to be at high risk for death or complications with surgery.

Read more

To category page